Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMID 2170267)

Published in Hepatology on October 01, 1990

Authors

X Calvet1, J Bruix, P Ginés, C Bru, M Solé, R Vilana, J Rodés

Author Affiliations

1: Liver Unit, Hospital Clínic i Provincial, Barcelona, Spain.

Articles citing this

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut (2001) 4.12

Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology (2012) 2.40

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int (2008) 2.10

Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol (2006) 1.89

Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45

Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol (2004) 1.27

Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg (1998) 1.20

Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital. World J Gastroenterol (2000) 1.14

Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol (2008) 1.01

Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine. Pancreas (2011) 1.00

Gender-based outcomes differences in unresectable hepatocellular carcinoma. Hepatol Int (2007) 0.99

Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy. World J Surg (2008) 0.94

Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer (1994) 0.94

Management of hepatocellular carcinoma in Japan. J Gastroenterol (2006) 0.87

Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma. Med Sci Monit (2013) 0.87

Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience. Korean J Intern Med (2013) 0.85

Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma. Hepat Mon (2014) 0.83

Prognostic impact of Fas ligand on hepatocellular carcinoma after hepatectomy. World J Surg (2004) 0.82

The mutational landscape of hepatocellular carcinoma. Clin Mol Hepatol (2015) 0.82

Active treatments are a rational approach for hepatocellular carcinoma in elderly patients. World J Gastroenterol (2013) 0.80

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma. Onco Targets Ther (2015) 0.77

Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular carcinoma. Mol Clin Oncol (2013) 0.77

Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma. Korean J Intern Med (1996) 0.77

Differential proteomic analysis of gender-dependent hepatic tumorigenesis in Hras12V transgenic mice. Mol Cell Proteomics (2017) 0.76

Liver disease. Postgrad Med J (1994) 0.76

Systems biology approaches to decoding the genome of liver cancer. Cancer Res Treat (2011) 0.76

Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma. Case Rep Oncol (2010) 0.76

Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study. World J Surg Oncol (2016) 0.75

Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma. World J Gastroenterol (2011) 0.75

Decoding human liver cancer signatures. Gastrointest Cancer Res (2008) 0.75

Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration. J Hepatocell Carcinoma (2016) 0.75

Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease. Gastroenterology Res (2009) 0.75

Articles by these authors

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07

Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis (1999) 12.31

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology (2001) 6.88

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet (1995) 6.06

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 5.89

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 5.70

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology (1999) 5.64

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (1988) 4.32

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology (1998) 3.62

Compensated cirrhosis: natural history and prognostic factors. Hepatology (1987) 3.01

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology (1996) 2.96

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet (1989) 2.94

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver. J Hepatol (2000) 2.79

Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73

Effects of somatostatin on renal function in cirrhosis. Gastroenterology (1992) 2.68

Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology (2000) 2.57

Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology (1995) 2.47

Endoscopic ultrasound-guided fine-needle aspiration and trucut biopsy in the diagnosis of gastric stromal tumors: a randomized crossover study. Endoscopy (2010) 2.40

Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology (1991) 2.29

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology (1994) 2.27

Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol (2000) 2.22

Cell-density-dependent expression of Borrelia burgdorferi lipoproteins in vitro. Infect Immun (1997) 2.19

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol (1999) 2.14

Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology (1998) 2.10

[Diagnosis of renal carcinoma in acquired cystic renal disease. Usefulness of echography in detection during subclinical phase]. Med Clin (Barc) (1991) 2.04

The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology (1996) 2.00

Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology (1993) 1.97

Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology (1989) 1.97

Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol (1999) 1.92

Circulating levels of endothelin in cirrhosis. Gastroenterology (1993) 1.91

Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol (2001) 1.89

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology (1998) 1.87

Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet (1989) 1.86

Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol (1986) 1.84

Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology (1998) 1.83

Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology (1993) 1.79

Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma. Am J Transplant (2014) 1.77

Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology (1988) 1.76

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol (1998) 1.76

Adenoid cystic carcinoma of the breast: mammographic appearance and pathologic correlation. AJR Am J Roentgenol (1998) 1.73

Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg (1996) 1.73

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology (1996) 1.68

Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67

Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology (1990) 1.67

Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology (1993) 1.67

Fulminant hepatic failure. Lancet (1997) 1.66

In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology (2001) 1.66

Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology (1999) 1.64

Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene (2003) 1.63

Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology (2001) 1.62

Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology (1998) 1.60

Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology (1998) 1.60

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis (1976) 1.59

Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet (1993) 1.57

Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology (1992) 1.57

Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol (1998) 1.55

Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology (1994) 1.54

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology (2001) 1.53

K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. J Clin Oncol (1999) 1.53

Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J Hepatol (2000) 1.53

World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis (2010) 1.52

Schistosomiasis of the male genital tract: transrectal sonographic findings. J Urol (1997) 1.52

New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene (2006) 1.52

Cyclosporine-associated mutism in liver transplant patients. Neurology (1996) 1.49

Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver. J Hepatol (1998) 1.49

Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol (1994) 1.49

A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol (2001) 1.49

Endoscopic sclerotherapy in upper gastrointestinal bleeding due to the Mallory-Weiss syndrome. Am J Gastroenterol (1994) 1.48

The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology (1996) 1.48

Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology (1992) 1.45

Renal oncocytoma in a long-term renal-transplant recipient. Nephrol Dial Transplant (1995) 1.45

[60-year-old man with hepatic cirrhosis of 33 years of evolution affected by acute respiratory process and neurological lesion]. Med Clin (Barc) (1999) 1.43

Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. Am J Physiol (1992) 1.43

Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology (1997) 1.43

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology (1992) 1.42